Signify Health, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Bradford Kyle Armbrester
- Full Time Employees
- 2,100
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 4055 Valley View Lane Dallas TX United States of America 75244
- IPO Date
- Feb 11, 2021
- CIK
- 0001828182
- Website
- signifyhealth.com
- Similar Companies
- Business
- Signify Health, Inc. (SGFY) operates as a leading healthcare technology platform that leverages advanced analytics, technology and a nationwide network of clinicians to deliver in-home health evaluations, diagnostic and preventive services, accountable care organization enablement, provider enablement services and return-to-home solutions primarily for health plans, Medicare Advantage and Medicaid payers and risk-bearing providers across the United States. The company provides comprehensive in-home assessments conducted by licensed clinicians that include physical and behavioral health evaluations, medication reviews, screenings for chronic conditions such as peripheral artery disease, chronic obstructive pulmonary disease, chronic kidney disease and diabetes, spirometry testing and social determinants of health analysis; it also offers virtual visits and facility-based services to close care gaps, improve health outcomes and support value-based payment programs. Founded in 2017 through the merger of Advance Health and CenseoHealth and headquartered in Dallas, Texas, Signify Health conducts over 3.2 million in-home health evaluations annually, serving millions of members nationwide. CVS Health completed its $8 billion acquisition of Signify Health in March 2023, integrating its capabilities into a broader health services ecosystem that includes Oak Street Health and driving 39% revenue growth in Q4 2023 through expanded multi-payer engagements; recently, the company expanded its in-home diagnostics portfolio with new spirometry testing for COPD detection in select areas during 2025.
Is it time to buy this market-beaten growth stock?
Strength Seen in Signify (SGFY): Can Its 5.8% Jump Turn into More Strength?
CVS Health to Close Acquisition of Signify Health
This Boring Business Could Be a Secret Weapon to Beat the Market
These Are the Top 10 Holdings of George Soros
3 Growth Stocks That Could Disrupt the Healthcare Industry
Cardinal Health's Outcomes™ collaborates with Signify Health to offer in-home medication therapy management
Time to Buy CVS Stock Before Crucial Q4 Earnings?
Mergers and Acquisitions in 2023 Off To A Strong Start
Time to Buy CVS or Oak Street Health Stock on Potential Acquisition?
How 2022's Biggest Healthcare Gainers Could Fare In 2023
Checking Signify Health Before The CVS Transaction
The Top (and Bottom) Five Stocks of 2022
These Were The Five Best And Worst Performing Mid-Cap Stocks In Q3 2022
The Top 5 Stocks Cathie Wood Bought and Sold This Week
SIGNIFY HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Signify Health, Inc. - SGFY
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMTX, FMTX, TRQ, SGFY
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ECOM, SGFY, EQ, MTCR
Is CVS' Acquisition of Signify in Danger of Falling Through?
Why CVS Health (CVS) Is Buying Signify Health (SGFY) For About $8 Billion